Prosecution Insights
Last updated: August 08, 2026

Rowan University

10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (80%)
2
Medium (20%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (10%)
§103 only1 (10%)
Double-patenting + other1 (10%)
Multi-statute (no §101)7 (70%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
10% of docket
3
Mechanical / Eng
30% of docket
1
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DRISCOLL, LORA E BARNHART 1 31.7% +20.3%
MPAMUGO, CHINYERE 1 27.6% +27.4%
WOODWARD, NATHANIEL T 1 84.6% +14.4%
DUKE, EMMANUEL E 1 68.7% +27.4%
LAU, JONATHAN S 1 64.0% -18.2%
LIU, XUE H 1 73.1% +12.4%
SPENCE, JENNIFER SUZANNE 1 66.1% +50.7%
HELM, CARALYNNE E 1 28.8% +49.6%
FONTAINHAS, AURORA M 1 37.9% +48.8%
MATTHEWS, CHRISTINE HOPKINS 1 71.5% +31.3%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18739516 MULTI-SESSION SUPPORT SYSTEM FOR HEALTHCARE PROFESSIONALS MPAMUGO, CHINYERE 146d overdue
18673752 METHODS OF MODIFYING CELLULOSE CRYSTALLINITY LAU, JONATHAN S 18d overdue
17820815 DIAGNOSTIC BIOMARKERS FOR DETECTING, SUBTYPING, AND/OR ASSESSING PROGRESSION OF MULTIPLE SCLEROSIS FONTAINHAS, AURORA M 18d overdue
18679011 ROOM AIR MONITORING DEVICE DUKE, EMMANUEL E 3d overdue
18679043 DEVICE FOR TESTING VAPORIZABLE FLUIDS IN A HUMAN AIRWAY MODEL WOODWARD, NATHANIEL T
18216337 THREE-DIMENSIONAL PRINTABLE BIOCOMPATIBLE PHOTOPOLYMERIZABLE INK WITH SPATIALLY CONTROLLED DUAL PROTEIN MOTIFS FOR CO-CULTURE FUNCTIONALITY SPENCE, JENNIFER SUZANNE
18091615 OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME HELM, CARALYNNE E
17830888 DEVICE PROVIDING NEUROTHERAPEUTIC INTERVENTION VIA MULTI-MODAL ENERGY THERAPY MATTHEWS, CHRISTINE HOPKINS

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18739516 MULTI-SESSION SUPPORT SYSTEM FOR HEALTHCARE PROFESSIONALS MPAMUGO, CHINYERE 146d overdue
17820815 DIAGNOSTIC BIOMARKERS FOR DETECTING, SUBTYPING, AND/OR ASSESSING PROGRESSION OF MULTIPLE SCLEROSIS FONTAINHAS, AURORA M 18d overdue
18679011 ROOM AIR MONITORING DEVICE DUKE, EMMANUEL E 3d overdue
18825927 DIAGNOSTIC AUTOANTIBODY PROFILES FOR THE DETECTION AND DIAGNOSIS OF NEURODEGENERATIVE DISEASES DRISCOLL, LORA E BARNHART
18679043 DEVICE FOR TESTING VAPORIZABLE FLUIDS IN A HUMAN AIRWAY MODEL WOODWARD, NATHANIEL T
18557099 SYSTEMS AND METHODS FOR FIBER ZONE-DRAWING AND/OR ZONE-ANNEALING LIU, XUE H
18216337 THREE-DIMENSIONAL PRINTABLE BIOCOMPATIBLE PHOTOPOLYMERIZABLE INK WITH SPATIALLY CONTROLLED DUAL PROTEIN MOTIFS FOR CO-CULTURE FUNCTIONALITY SPENCE, JENNIFER SUZANNE
18091615 OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME HELM, CARALYNNE E

Top Art Units

Art UnitApps
3991 1
3685 1
2855 1
3763 1
1693 1
1742 1
1633 1
1615 1
1675 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18825927 DIAGNOSTIC AUTOANTIBODY PROFILES FOR THE DETECTION AND DIAGNOSIS OF NEURODEGENERATIVE DISEASES DRISCOLL, LORA E BARNHART 3991 §112DPOther Non-Final OA Pending Sep 05, 2024
18739516 MULTI-SESSION SUPPORT SYSTEM FOR HEALTHCARE PROFESSIONALS MPAMUGO, CHINYERE 3685 §101§102 Non-Final OA 146d overdue Pending Jun 11, 2024
18679043 DEVICE FOR TESTING VAPORIZABLE FLUIDS IN A HUMAN AIRWAY MODEL WOODWARD, NATHANIEL T 2855 §103§112 Non-Final OA Pending May 30, 2024
18679011 ROOM AIR MONITORING DEVICE DUKE, EMMANUEL E 3763 §103§112 Non-Final OA 3d overdue Pending May 30, 2024
18673752 METHODS OF MODIFYING CELLULOSE CRYSTALLINITY LAU, JONATHAN S 1693 §102§112 Non-Final OA 18d overdue Pending May 24, 2024
18557099 SYSTEMS AND METHODS FOR FIBER ZONE-DRAWING AND/OR ZONE-ANNEALING LIU, XUE H 1742 §103 Non-Final OA Pending Oct 25, 2023
18216337 THREE-DIMENSIONAL PRINTABLE BIOCOMPATIBLE PHOTOPOLYMERIZABLE INK WITH SPATIALLY CONTROLLED DUAL PROTEIN MOTIFS FOR CO-CULTURE FUNCTIONALITY SPENCE, JENNIFER SUZANNE 1633 §103§112 Non-Final OA Pending Jun 29, 2023
18091615 OPTICALLY CLEAR, IN-SITU FORMING BIODEGRADABLE NANO-CARRIERS FOR OCULAR THERAPY, AND METHODS USING SAME HELM, CARALYNNE E 1615 §103§112 Final Rejection Pending Dec 30, 2022
17820815 DIAGNOSTIC BIOMARKERS FOR DETECTING, SUBTYPING, AND/OR ASSESSING PROGRESSION OF MULTIPLE SCLEROSIS FONTAINHAS, AURORA M 1675 §102§112 Non-Final OA 18d overdue Pending Aug 18, 2022
17830888 DEVICE PROVIDING NEUROTHERAPEUTIC INTERVENTION VIA MULTI-MODAL ENERGY THERAPY MATTHEWS, CHRISTINE HOPKINS 3791 §102§103§112 Final Rejection Pending Jun 02, 2022

Managing Rowan University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month